acrolein has been researched along with Dyslipidemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barre, DE; Mizier-Barre, KA | 1 |
| Atlı Şekeroğlu, Z; Aydın, B; Şekeroğlu, V | 1 |
| Hayes, AW; Karimani, A; Karimi, G; Mehri, S; Zeinali, M; Zirak, MR | 1 |
| Barski, OA; Bhatnagar, A; Conklin, DJ; Juvan, P; Lesgards, JF; Liu, S; Prough, RA; Rezen, T; Rozman, D; Srivastava, S; Vladykovskaya, E | 1 |
| Bhatnagar, A; Conklin, DJ; Haberzettl, P; Juvan, P; Prough, RA; Rezen, T; Rozman, D; Srivastava, S | 1 |
2 review(s) available for acrolein and Dyslipidemia
| Article | Year |
|---|---|
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
Mechanisms behind the atherothrombotic effects of acrolein, a review.
Topics: Acrolein; Atherosclerosis; Dyslipidemias; Environmental Exposure; Enzyme Activation; Extracellular Matrix; Humans; Inflammation; Matrix Metalloproteinases; Plaque, Atherosclerotic; Thrombosis; Toxicokinetics | 2019 |
3 other study(ies) available for acrolein and Dyslipidemia
| Article | Year |
|---|---|
Effects of whey protein and conjugated linoleic acid on acrolein-induced cardiac oxidative stress, mitochondrial dysfunction and dyslipidemia in rats.
Topics: Acrolein; Animals; Dyslipidemias; Environmental Pollutants; Linoleic Acids, Conjugated; Lipids; Male; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley; Whey Proteins | 2018 |
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.
Topics: Acrolein; Animals; Apolipoproteins E; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Dyslipidemias; Gene Expression Regulation; Lipase; Lipoproteins; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2010 |
Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase.
Topics: Acrolein; Acute-Phase Reaction; Animals; Apolipoproteins E; Cholesterol; Dyslipidemias; Gene Expression Regulation; Hydroxymethylglutaryl CoA Reductases; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Serum Amyloid A Protein; Simvastatin; Toxicity Tests, Acute; Toxicity Tests, Chronic; Triglycerides; Xenobiotics | 2011 |